Status:
ACTIVE_NOT_RECRUITING
Non-invasive Detection of Breast Cancer by Breath Analysis
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions:
Breast Neoplasm Female
Eligibility:
FEMALE
18-98 years
Brief Summary
The goal of this prospective observational study is to compare the exhaled breath profiles of patient with invasive breast cancer and control subjects in the perspective of a diagnostic application in...
Eligibility Criteria
Inclusion
- be \>= 18 years
- Patients
- a patients at early stage of breast cancer 2.b exahled breath collected and analysed at the baseline before any surgical or pharmacological treatment
- 3\. Controls 3.1 subjects with negative breast imaging (BI-RADS= 1,2) 3.2 exhaled breath collected and analysed on the day of breast screening
- \-
Exclusion
- any cancer in the 5 years before the inclusion
- major surgery within 4 weeks before the inclusion
- previous or concomitant long-term treatment with systemic steroids or immunosuppressive/immunomodulating drugs
- concomitant acute infection, viral hepatitis, HIV infection, COVID19 infection or other serious concomitant medical disorders
- organ allograft
- \-
Key Trial Info
Start Date :
June 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06499077
Start Date
June 3 2021
End Date
December 1 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Nazionale Tumori
Milan, Italy